CONNIE MATSUI
CIK 1236537 · EVP, Corp. Strategy and Comm. · last filed 2026-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$14.16M
Companies
5
Total Filings
50
Lifetime Open-Market Net
-$3.33M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| STRO | Director | 50,000 | $28.80 | $1.44M | $40.0K | 10 | 2026-06-09 |
| ARTL | Director | — | $1.36 | — | $0 | 4 | 2026-02-02 |
| HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Director | 183,035 | — | — | -$2.16M | 25 | 2024-12-03 |
| ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Director | 56,667 | $0.01 | $317 | $50.0K | 8 | 2024-03-01 |
| BIIB | EVP, Corp. Strategy and Comm. | 63,603 | $200.05 | $12.72M | -$1.26M | 3 | 2007-02-14 |
Recent Filings · Page 4 of 5
50 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-26 | STRO | Grant (A) | — | $0 | EDGAR |
| 2019-05-03 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Grant (A) | +12,173 | $0 | EDGAR |
| 2018-12-10 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Gift (G) | −15,000 | $0 | EDGAR |
| 2018-05-02 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Grant (A) | +10,363 | $0 | EDGAR |
| 2017-09-21 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Gift (G) | −15,000 | $0 | EDGAR |
| 2017-05-09 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Exer (M) | +10,000 | $103.7K | EDGAR |
| 2017-05-05 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Grant (A) | +14,135 | $0 | EDGAR |
| 2016-05-06 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Grant (A) | +20,202 | $0 | EDGAR |
| 2015-09-15 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Exer (M) | +20,000 | $72.7K | EDGAR |
| 2015-05-07 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Grant (A) | +13,175 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.